Risk factors for cisplatin-induced long-term nephrotoxicity in pediatric cancer survivors


Arga M., Oguz A., Pinarli F. G. , Karadeniz C., Citak E. C. , Emeksiz H. C. , et al.

PEDIATRICS INTERNATIONAL, cilt.57, ss.406-413, 2015 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 57 Konu: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1111/ped.12542
  • Dergi Adı: PEDIATRICS INTERNATIONAL
  • Sayfa Sayısı: ss.406-413

Özet

BackgroundThe aim of this study was to compare the nephrotoxicity risk of cisplatin (CPL) and ifosfamide (IFO) combination treatment (CT) with that of CPL alone and to evaluate the prevalence of CPL-induced long-term nephrotoxicity in pediatric cancer survivors (CS).